ATE394125T1 - Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur abgabe des therapeutischen, diagnostischen oder kosmetischen mittels in ein gewebe - Google Patents

Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur abgabe des therapeutischen, diagnostischen oder kosmetischen mittels in ein gewebe

Info

Publication number
ATE394125T1
ATE394125T1 AT03744968T AT03744968T ATE394125T1 AT E394125 T1 ATE394125 T1 AT E394125T1 AT 03744968 T AT03744968 T AT 03744968T AT 03744968 T AT03744968 T AT 03744968T AT E394125 T1 ATE394125 T1 AT E394125T1
Authority
AT
Austria
Prior art keywords
therapeutic
diagnostic
nettle
cosmetic agent
cells
Prior art date
Application number
AT03744968T
Other languages
English (en)
Inventor
Tamar Lotan
Shimon Eckhouse
Esther Shaoul
Original Assignee
Nanocyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanocyte Inc filed Critical Nanocyte Inc
Application granted granted Critical
Publication of ATE394125T1 publication Critical patent/ATE394125T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03744968T 2002-03-26 2003-03-20 Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur abgabe des therapeutischen, diagnostischen oder kosmetischen mittels in ein gewebe ATE394125T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36726102P 2002-03-26 2002-03-26

Publications (1)

Publication Number Publication Date
ATE394125T1 true ATE394125T1 (de) 2008-05-15

Family

ID=28454843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03744968T ATE394125T1 (de) 2002-03-26 2003-03-20 Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur abgabe des therapeutischen, diagnostischen oder kosmetischen mittels in ein gewebe

Country Status (7)

Country Link
US (2) US7611723B2 (de)
EP (1) EP1519755B1 (de)
AT (1) ATE394125T1 (de)
AU (1) AU2003215878A1 (de)
DE (1) DE60320793D1 (de)
IL (1) IL164191A0 (de)
WO (1) WO2003079967A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632522B2 (en) 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
EP1379127B1 (de) * 2000-09-28 2013-04-17 Nanocyte Inc. Methoden, zusammensetzungen und vorrichtungen unter verwendung von stechzellen/kapseln zur abgabe eines therapeutischen mittels oder eines kosmetischen mittels in ein gewebe
US20060222656A1 (en) * 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
DE60320793D1 (de) 2002-03-26 2008-06-19 Nanocyte Inc Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebe
CA2536026A1 (en) * 2003-08-22 2005-05-06 Nucleonics Inc. Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments
ES2612752T3 (es) 2003-12-18 2017-05-18 Metronom Health, Inc. Biosensor implantable y métodos de uso del mismo
US8834862B2 (en) * 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
WO2007007316A1 (en) 2005-07-07 2007-01-18 Cbd Technologies Ltd. Compositions and methods comprising stinging capsules/cells for delivering a biologically active agent into a plant cell
DE102007035238A1 (de) * 2007-07-27 2009-01-29 Christian-Albrechts-Universität Zu Kiel Biologisches Effektmonitoring mittels transgener Hydra
WO2017142993A1 (en) * 2016-02-16 2017-08-24 Manus Biosynthesis, Inc. Secondary metabolite screening system
WO2018178969A1 (en) * 2017-03-28 2018-10-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Transformed organisms with stinging cells expressing an exogenous protein of interest
WO2024006793A1 (en) * 2022-06-29 2024-01-04 Battelle Memorial Institute Nematocysts as natural microinjectors

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US614960A (en) * 1898-11-29 Hair-clipper
US3321188A (en) * 1965-10-04 1967-05-23 Broadway Imp S Paint mixing device
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5459047A (en) * 1986-07-01 1995-10-17 Genetics Institute, Inc. BMP-6 proteins
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5073488A (en) 1988-11-29 1991-12-17 Minnesota Mining And Manufacturing Company Rapid method for determining efficacy of a sterilization cycle and rapid read-out biological indicator
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5162378A (en) 1990-04-20 1992-11-10 Revlon Consumer Products Corporation Silicone containing water-in-oil microemulsions having increased salt content
US5885260A (en) 1991-05-30 1999-03-23 Mehl, Sr.; Thomas L. Freeze-dried liposome delivery system for application of skin treatment agents
US5641508A (en) * 1994-01-13 1997-06-24 Anticancer, Inc. Method for delivering melanin to hair follicles
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5362442A (en) 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
US5624803A (en) * 1993-10-14 1997-04-29 The Regents Of The University Of California In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
FR2729855A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
US6416960B1 (en) 1996-08-08 2002-07-09 Prolume, Ltd. Detection and visualization of neoplastic tissues and other tissues
EP0952850A2 (de) 1996-12-31 1999-11-03 Altea Technologies, Inc. Mikroporation von gewebe zur bioaktive-mittel-abgabe
US6338837B1 (en) 1997-05-29 2002-01-15 Nidaria Technology Ltd. Compositions and methods for inhibiting nematocyst discharge
US6132747A (en) 1997-05-29 2000-10-17 Nidaria Technology Ltd. Compositions and methods for inhibiting nematocyst discharge
US6406709B1 (en) 1997-05-29 2002-06-18 Nidaria Technology Ltd. Method for inhibiting nematocyst discharge
US6173202B1 (en) 1998-03-06 2001-01-09 Spectrx, Inc. Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
EP1059883B1 (de) 1998-03-06 2008-02-06 SPECTRX, Inc. Integrierte porations-, sammel- und analysevorrichtung und verfahren dafür
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
US6630001B2 (en) 1998-06-24 2003-10-07 International Heart Institute Of Montana Foundation Compliant dehyrated tissue for implantation and process of making the same
DK1124607T3 (da) 1998-07-14 2009-01-26 Altea Therapeutics Corp Kontrolleret fjernelse af biologisk membran ved hjælp af pyroteknisk ladning til transmembran transport
AU5004299A (en) 1998-07-21 2000-02-14 Altea Technologies, Inc. System and method for continuous analyte monitoring
JP2002521077A (ja) 1998-07-21 2002-07-16 スペクトルクス，インコーポレイティド 連続式流体収集兼検出装置の液体管理システムおよび方法
EP1112021A1 (de) 1998-09-10 2001-07-04 Spectrx, Inc. Eigenschaftskompensation zur detektion eines analyten und/oder kontinuierlichen überwachung
AU1728701A (en) 1999-11-29 2001-06-04 Nidaria Technology Ltd. A composition and method for inhibiting polar capsule discharge and protecting asubject from nematocyst sting
ATE282955T1 (de) 2000-04-17 2004-12-15 Organ Recovery Systems Inc Neues aufwärmverfahren für cryokonservierte proben
EP1379127B1 (de) 2000-09-28 2013-04-17 Nanocyte Inc. Methoden, zusammensetzungen und vorrichtungen unter verwendung von stechzellen/kapseln zur abgabe eines therapeutischen mittels oder eines kosmetischen mittels in ein gewebe
US20070281037A9 (en) 2000-09-28 2007-12-06 Nanocyte Inc. Sterile preparations and compositions including stinging capsules and methods of producing and using same
US7632522B2 (en) * 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
DE60320793D1 (de) * 2002-03-26 2008-06-19 Nanocyte Inc Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebe
US20030189850A1 (en) 2002-04-09 2003-10-09 Toyo Boseki Kabushiki Kaisha Cell array system
JP2004344036A (ja) 2003-05-21 2004-12-09 Fujitsu Ltd 物質導入装置及び物質導入システム
US20050181978A1 (en) * 2003-11-20 2005-08-18 Rasmus Rojkjaer Therapeutic use of factor XI
US20060099272A1 (en) 2004-11-05 2006-05-11 Nanocyte Inc. Compositions and kits including dehydrated stinging capsules and methods of producing and using same
US7644087B2 (en) 2005-02-24 2010-01-05 Xeround Systems Ltd. Method and apparatus for data management
US8834862B2 (en) 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent

Also Published As

Publication number Publication date
EP1519755A2 (de) 2005-04-06
WO2003079967A3 (en) 2005-02-03
US7611723B2 (en) 2009-11-03
US20100111869A1 (en) 2010-05-06
WO2003079967A2 (en) 2003-10-02
US8337868B2 (en) 2012-12-25
IL164191A0 (en) 2005-12-18
DE60320793D1 (de) 2008-06-19
US20060039897A1 (en) 2006-02-23
EP1519755A4 (de) 2006-11-22
AU2003215878A1 (en) 2003-10-08
AU2003215878A8 (en) 2003-10-08
EP1519755B1 (de) 2008-05-07

Similar Documents

Publication Publication Date Title
Iorizzo et al. Biorejuvenation: theory and practice
ATE394125T1 (de) Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur abgabe des therapeutischen, diagnostischen oder kosmetischen mittels in ein gewebe
EP2422797A3 (de) Zusammensetzungen enhaltend menschliche embryonale Stammzellen und ihre Derivate, Verwendung davon und Verfahren zur ihrer Vorbereitung
MX2010003019A (es) Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
CN111110623A (zh) 自体修复小小针营养液配方
WO2016065688A1 (zh) 一种能激活肌肤活力和抗衰老的精华液
WO2012014081A3 (en) Use of a composition comprising a peptidic fava bean extract for the stimulation of hair growth
Gonçalves Use of enzymes in cosmetics: proposed enzymatic peel procedure
HUP9901188A2 (hu) Új, meghatározott enzimkeverékek sejtkinyeréshez és sebkezeléshez
CN105496828A (zh) 一种水母抗氧化活性蛋白护肤品
ATE462477T1 (de) Verwendung eines quinoa-extrakts als kosmetisches und pharmazeutisches schlankheitsmittel und/oder als mittel zur verhinderung der formierung neuer fette im menschlichen körper
CN106166326A (zh) 一种非介入导入方法
CN105496836A (zh) 一种功能型抗老化面膜
CN201394163Y (zh) 一种理疗板
AU2016100373A4 (en) THE INVENTION TITLE IS "K.D. BIO-BEAUTY". The description name is HYALURONIC ACID,NONA PLACENTA,GRAPE SEED EXTRACT, COLLAGEN SERUM
CN110038192A (zh) 一种通过水光针针剂组改善面部雀斑和黄褐斑的方法
JP2011063520A5 (de)
UA47832U (uk) Спосіб уповільнення процесів старіння шкіри та омолодження
CN108450956A (zh) 一种美容营养液
JP2025165570A (ja) 美容セット
CN106491855A (zh) 一种激活肌肤细胞活性恢复弹力的枸杞多糖美容保健品
CN106691992A (zh) 一种珍珠面膜的组合配方
CN201481775U (zh) 循经减肥手
TW202330009A (zh) 外用皮膚美白複合液
ATE355083T1 (de) Kit aus polyakrylamidgel zur herstellung einer kapsel im gewebe eines säugetierorganismus und tierischen allogenen oder xenogenen zellen , zur behandlung von onkologischen krankheiten und der diabetes mellitus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties